Tag Archive for: Amber Implants

Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix® Spinal System

/in

Experienced MedTech leader to guide Amber Implants’ transition from development into commercialization following  FDA clearance of the VCFix® Spinal System Company preparing for U.S. market launch in 2026 THE HAGUE, The Netherlands, Nov. 6, 2025 /PRNewswire/ — Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced the appointment of Vincent Gardès as Chief Executive […]

Read more

Amber Implants Secures FDA 510(k) Clearance for VCFix® Spinal System: A Next-Generation Solution for Vertebral Compression Fractures

/in

FDA clearance confirms robust safety and performance of VCFix® Spinal System, a breakthrough treatment for vertebral compression fractures US commercial pilot launch planned for early 2026, followed by broader physician availability from summer 2026 One-year trial data show significant clinical improvements, supporting VCFix® Spinal System as a potential new standard of care The Hague, The […]

Read more

Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical of VCFix® Spinal System

/in

One-year follow-up data from first-in-human trial shows significant improvements in key clinical performance outcomes  This data supports a strong safety profile for the VCFix® Spinal System for the treatment of vertebral compression fractures The Hague, The Netherlands, 3 June 2025 – Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces […]

Read more

Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System

/in

The Hague, Netherlands, 11 June 2024: Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces that it has completed enrolment of its first-in-human clinical trial with its innovative VCFix® Spinal System. The VCFix® Spinal System is the first device that does not rely on bone […]

Read more

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

/in

Pioneering Safer and More Effective Solutions for Vertebral Fractures The Hague, Netherlands, 3 October 2023: Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the official start of the clinical trial for the VCFix® Spinal System. Read more…

Read more